What are the implications of using AI to attempt to bring back extinct animals

Using AI-driven methods to recreate extinct animals would outpace existing laws and pose novel legal and governance challenges. New regulatory frameworks would be needed to address: - Biosafety and biosecurity: Existing biosafety rules focus on laboratory containment and known pathogens. De-extinct organisms could carry unforeseen ecological or health risks (novel pathogens, gene flow into wild populations). Regulations must set standards for risk assessment, containment, monitoring, and emergency response specific to engineered or resurrected species (WHO, Convention on Biological Diversity guidance on synthetic biology). - Liability and responsibility: Who bears legal responsibility if an introduced or escaped organism causes ecological harm, economic loss, or human health effects? Clear rules are needed for producers, funders, releasing organizations, and host governments to allocate civil and criminal liability, insurance requirements, and remediation obligations. - Transboundary movement and jurisdiction: Organisms do not respect national borders. International agreements must govern cross-border transfer, release, and monitoring of engineered species to prevent disputes and ecological spillover. This includes harmonizing import/export rules, prior informed consent, and dispute-resolution mechanisms (Cartagena Protocol on Biosafety analogues). - Intellectual property and access: Patents on genomes, AI-designed organisms, or restoration processes raise questions about access, benefit-sharing, and control over living heritage. Laws must balance innovation incentives with public interest and indigenous/community rights connected to species. - Ethical and participatory governance: Legal frameworks should require transparent decision processes, public consultation, and involvement of affected communities (including indigenous peoples) before releases, aligning with environmental law principles and the precautionary principle. References: Convention on Biological Diversity — Cartagena Protocol on Biosafety; WHO guidance on synthetic biology and biosafety; scholarly discussions on de‑extinction governance (e.g., Shapiro 2015; Redford et al. 2019).